Alana Biggers

Alana Biggers

Auto-generated profile, based on publicly available information

Alana Biggers

University of Illinois Chicago

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in Mindfulness
Verified
Journal Article
Closed access
PDF file
ABAlana Biggers
Alana Biggers
CSClaire Adams Spears
Claire Adams Spears
KSKimberly Sanders
Kimberly Sanders
JOJason Ong
Jason Ong
LSLisa K. Sharp
Lisa K. Sharp
BGBen S. Gerber
Ben S. Gerber

1 March 2019 in Journal of Clinical & Translational Endocrinology
Verified
Journal Article
Open access
ABAlana Biggers
Alana Biggers
LSLisa K. Sharp
Lisa K. Sharp
HNHATAIKARN NIMITPHONG
HATAIKARN NIMITPHONG
SSSunee Saetung
Sunee Saetung
NSNantaporn Siwasaranond
Nantaporn Siwasaranond
SRSirimon Reutrakul
Sirimon Reutrakul
We analyzed two cohorts of people with type 2 diabetes to evaluate the relationships between depression, sleep quality, and history of hypoglycemia. Two adult cohorts from Chicago (n = 193) and Bangkok, Thailand (n = 282) with type 2 diabetes completed questionnaires to assess sleep quality, depressive symptoms, and hypoglycemia frequency. Proportional odds logistic regression models for each cohort adjusted for duration of therapy, insulin and sulfonylurea management, and other factors. Those with hypoglycemia in both cohorts had a longer duration of diabetes, greater use of insulin, and worse sleep quality. The Chicago cohort used less sulfonylureas but had higher depressive symptom scores. The Thailand cohort had greater sulfonylurea use. In the final Thailand regression model, depressive symptoms were independently associated with hypoglycemia frequency. In both final Chicago and Thailand models, sleep quality was not associated with hypoglycemia frequency. In the Thailand cohort, depressive symptoms were associated with hypoglycemia frequency.

10 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MOManoela Lima Oliveira
Manoela Lima Oliveira
ABAlana Biggers
Alana Biggers
Vanessa OddoVanessa Oddo
Vanessa Oddo
KNKeith B. Naylor
Keith B. Naylor
Zhengjia ChenZhengjia Chen
Zhengjia Chen
LTLisa Tussing-Humphreys
Lisa Tussing-Humphreys
Early-onset colorectal cancer (EOCRC) is defined as a diagnosis of colorectal cancer (CRC) in individuals younger than 50 years of age. While overall CRC rates in the United States (US) decreased between 2001 and 2018, EOCRC rates have increased. This research project aims to evaluate the feasibility and acceptability of Time-Restricted Eating (TRE), Mindfulness, or TRE combined with Mindfulness among young to middle-aged adults at risk of EOCRC. Forty-eight participants will be randomly assigned to one of four groups: TRE, Mindfulness, TRE and Mindfulness, or Control. Data on feasibility, adherence, and acceptability will be collected. Measures assessed at baseline and post-intervention will include body weight, body composition, dietary intake, physical activity, sleep behavior, circulating biomarkers, hair cortisol, and the gut microbiome. The effects of the intervention on the following will be examined: (1) acceptability and feasibility; (2) body weight, body composition, and adherence to TRE; (3) circulating metabolic, inflammation, and oxidative stress biomarkers; (4) intestinal inflammation; and (5) the gut microbiome. TRE, combined with Mindfulness, holds promise for stress reduction and weight management among individuals at risk of EOCRC. The results of this pilot study will inform the design and development of larger trials aimed at preventing risk factors associated with EOCRC.

10 March 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
LSLisa Kay Sharp
Lisa Kay Sharp
ABAlana Biggers
Alana Biggers
RPRosanne Perez
Rosanne Perez
JHJulia Henkins
Julia Henkins
JTJessica Tilton
Jessica Tilton
BGBen S Gerber
Ben S Gerber
Background: Aggressive management of blood glucose, blood pressure, and cholesterol through medication and lifestyle adherence is necessary to minimize the adverse health outcomes of type 2 diabetes. However, numerous psychosocial and environmental barriers to adherence prevent low-income, urban, and ethnic minority populations from achieving their management goals, resulting in diabetes complications. Health coaches working with clinical pharmacists represent a promising strategy for addressing common diabetes management barriers. Mobile health (mHealth) tools may further enhance their ability to support vulnerable minority populations in diabetes management. Objective: The aim of this study is to evaluate the impact of an mHealth clinical pharmacist and health coach–delivered intervention on hemoglobin A1c (HbA1c, primary outcome), blood pressure, and low-density lipoprotein (secondary outcomes) in African-Americans and Latinos with poorly controlled type 2 diabetes. Methods: A 2-year, randomized controlled crossover study will evaluate the effectiveness of an mHealth diabetes intervention delivered by a health coach and clinical pharmacist team compared with usual care. All patients will receive 1 year of team intervention, including lifestyle and medication support delivered in the home with videoconferencing and text messages. All patients will also receive 1 year of usual care without team intervention and no home visits. The order of the conditions received will be randomized. Our recruitment goal is 220 urban African-American or Latino adults with uncontrolled type 2 diabetes (HbA1c ≥8%) receiving care from a largely minority-serving, urban academic medical center. The intervention includes the following: health coaches supporting patients through home visits, phone calls, and text messaging and clinical pharmacists supporting patients through videoconferences facilitated by health coaches. Data collection includes physiologic (HbA1c, blood pressure, weight, and lipid profile) and survey measures (medication adherence, diabetes-related behaviors, and quality of life). Data collection during the second year of study will determine the maintenance of any physiological improvement among participants receiving the intervention during the first year. Results: Participant enrollment began in March 2017. We have recruited 221 patients. Intervention delivery and data collection will continue until November 2021. The results are expected to be published by May 2022. Conclusions: This is among the first trials to incorporate health coaches, clinical pharmacists, and mHealth technologies to increase access to diabetes support among urban African-Americans and Latinos to achieve therapeutic goals. International Registered Report Identifier (IRRID): DERR1-10.2196/17170

1 January 2021 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
ABAlana Biggers
Alana Biggers
JHJulia Henkins
Julia Henkins
IBIsaye Barton
Isaye Barton
CHColin Hubbard
Colin Hubbard
RPRose Perez
Rose Perez
BGBen S. Gerber
Ben S. Gerber
Study Objectives:Text messaging (TM) may provide an inexpensive and convenient method for self-report sleep assessment. This pilot study evaluated the feasibility of a TM sleep diary among a racial...

26 January 2024 in The American Journal of Medicine
Verified
Journal Article
Closed access
ABAlana Biggers
Alana Biggers
ABAshley Binder
Ashley Binder
BGBen S. Gerber
Ben S. Gerber